Senju Pharmaceudical Co Ltd is categorized under Research and Development Laboratories in Beaverton, OR and active since 2004.
Senju Pharmaceudical Co Ltd was established in 2004, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact at the company’s single location by writing to 20000 Nw Walker Road # Jm, Beaverton, Oregon OR 97006 or by phoning (503) 748-5202. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Senju Pharmaceudical Co Ltd |
| Address: | 20000 Nw Walker Road # Jm, Beaverton, Oregon 97006 |
| Phone Number: | (503) 748-5202 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Senju Pharmaceudical Co Ltd was started in 2004 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact for inquiries that concern Senju Pharmaceudical Co Ltd by calling the company number (503) 748-5202, as your correspondence is most welcome. Additionally, the physical location of the single location of Senju Pharmaceudical Co Ltd can be found at the coordinates 45.532704,-122.879569 as well as the street address 20000 Nw Walker Road # Jm in Beaverton, Oregon 97006.
For its online presence, you may visit Senju Pharmaceudical Co Ltd’s website at and engage with its social media outlets through on Twitter and on Facebook.